Association of Alzheimer's Disease with APOE and IL-1α Gene Polymorphisms

American Journal of Alzheimer's Disease and other Dementias

Volumn 30, Issue 8, 2015, Pages 756-761

  Yildiz, Saliha Handan ^a   Erdogan, Mujgan Ozdemir ^a   Artan, Sevilhan ^b   Solak, Mustafa ^a   Yaman, Mehmet ^a   Ozbabalik, Belgin Demet ^b   Terzi, Evrim Suna Arikan ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; apolipoprotein E; interleukin 1 ; polymorphism

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; INTERLEUKIN 1ALPHA; IL1A PROTEIN, HUMAN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; GENETIC POLYMORPHISM; GENETICS; TURKEY;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HUMANS; INTERLEUKIN-1ALPHA; POLYMORPHISM, GENETIC; TURKEY;

EID: 84947285250     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317512461557     Document Type: Article

References (39)

1. Koivisto A., Genetic components of late-onset Alzheimer's disease with special emphasis on ApoE, IL-6, CYP46, SERPINA3 and PPAR3. Department of Neurology Series of Reports. 2006; 8.
2. Morris JC, Price JL,. Pathologic correlates of nondemented aging, mild cognitive impairment, and early stage Alzheimer's disease. J Mol Neurosci. 2001; 17 (2): 101-118.
3. Mayeux R,. Epidemiology of neurodegeneration. Annu Rev Neurosci. 2003; 26: 81-104.
4. Finckh U, van Hadeln K, Muller-Thomsen T, et al.Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2. Neurogenetics. 2003; 4 (4): 213-217.
5. Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD,. The diagnosis of young onset dementia. Lancet Neurol. 2010; 9 (8): 793-806.
6. Brown MS, Goldstein JL,. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986; 232 (4746): 34-47.
7. Raygani AV, Rahimi Z, Kharazi H, Tavilani H, Pourmotabbed T,. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease. Neurosci Lett. 2006; 408 (1): 68-72.
8. Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH,. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984, 25 (12): 1277-1294.
9. Ashford JW,. APOE genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci. 2004; 23 (3): 157-165.
10. Farrer LA, Cupples LA, Haines JL, et al.Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype Alzheimer disease: A Meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997; 278 (16): 1349-1356.
11. Corder EH, Saunders AM, Strittmatter WJ, et al.Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993; 261 (5123): 921-923.
12. Poirier J, Davigno J, Bouthillier D, Kogan S, Bertrand P, Gauthier S., Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993; 342 (8873): 697-699.
13. Nathan BP, Jiang Y, Wong GK, Shen F, Brewer GJ, Struble RG,. Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res. 2002; 928 (1-2): 96-105.
14. Deane R, Sagare A, Hamm K, et al.ApoE isoform-specific disruption of amyloid β peptide clearance from mouse brain. J Clin Invest. 2008; 118 (12): 4002-4013.
15. Dumanis SB, Tesoriero JA, Babus LW, et al.ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci. 2009, 29 (48): 15317-15322.
16. Rothwell NJ, Luheshi GN,. Interleukin in the brain: biology, pathology and therapeutic target. Trends Neurosci. 2000; 23 (12): 618-625.
17. Combarros O, Sánchez-Guerra M, Infante J, Llorca J, Berciano J,. Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease. J Neurol. 2002; 249 (9): 1242-1245.
18. Mrak RE, Griffin WS,. Interleukin-1 and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neurol. 2000; 59 (6): 471-476.
19. Li Y, Barger SW, Liu L, Mrak RE, Griffin WS,. S100beta induction of the proinflammatory cytokine interleukin-6 in neurons., J Neurochem. 2000; 74 (1): 143-150.
20. Li XQ, Zhang JW, Zhang ZX, Chen D, Qu QM,. Interleukin-1 gene cluster polymorphisms and risk of Alzheimer's disease in Chinese Han population., J Neural Transm. 2004; 111 (9), 1183-1190.
21. Grimaldi LM, Casadei VM, Ferri C, et al.Association of earlyonset Alzheimer's disease with an interleukin-1a gene polymorphism. Ann Neurol. 2000; 47 (3): 361-365.
22. Nicoll JA, Mrak RE, Graham DI, et al.Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol. 2000; 47 (3): 365-368.
23. Roses AD,. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med. 1996; 47: 387-400.
24. Saunders AM, Strittmatter WJ, Schmechel D, et al.Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993; 43 (8): 1467-1472.
25. Cedazo-Mínguez A., Apolipoprotein E, and Alzheimer's disease: Molecular mechanisms and therapeutic opportunities. J Cell Mol Med. 2007; 11 (6): 1227-1238.
26. Ohara T, Ninomiya T, Kubo M, et al.Apolipoprotein genotype for prediction of Alzheimer's disease in older Japanese: the Hisayama Study. J Am Geriatr Soc. 2011; 59 (6): 1074-1079.
27. Corder EH, Saunders AM, Risch NJ, et al.Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994; 7 (2): 180-184.
28. Schachter F, Faure-Delanef L, Guenot F, et al.Genetic associations with human longevity at the apo E and ACE loci. Nat Genet. 1994; 6 (1): 29-32.
29. Saunders AM, Roses AD,. Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke. 1993; 24 (9): 1416-1417.
30. de-Almada BV, de-Almeida LD, Camporez D, et al.Protective effect of the APOE-e3 allele in Alzheimer's disease. Braz J Med Biol Res. 2012; 45 (1): 8-12.
31. Ward A, Crean A, Mercaldi CJ, et al.Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology. 2012; 38 (1): 1-17.
32. de-Andrade FM, Larrandaburu M, Callegari-Jacques SM, Gastaldo G, Hutz MH,. Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population. Braz J Med Biol Res. 2000; 33 (5): 529-537.
33. Souza DR, de Godoy MR, Hotta J, et al.Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians. Braz J Med Biol Res. 2003; 36 (7): 919-923.
34. Qin X, Peng Q, Zeng Z, et al.Interleukin-1A -889C/T polymorphism and risk of Alzheimer's disease: a meta-analysis based on 32 case-control studies. J Neurol. 2012; 259 (8): 1519-1529.
35. Ki CS, Na DL, Kim DK, Kim HJ, Kim JW,. Lack of association of the interleukin-1alpha gene polymorphism with Alzheimer's disease in a Korean population. Ann Neurol. 2001; 49 (6): 817-818.
36. Green EK, Harris JM, Lemmon H, et al.Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD? Neurology. 2002; 58 (10): 1566-1568.
37. Pirskanen M, Hiltunen M, Mannermaa A, et al.Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer's disease and its influence on the extent of histopathological hallmark lesions of Alzheimer's disease. Dement Geriatr Cogn. 2002; 14 (3): 123-127.
38. Tsai SJ, Liu HC, Liu TY, Wang KY, Hong CJ,. Lack of association between the interleukin-1alpha gene C('889)T polymorphism and Alzheimer's disease in a Chinese population. Neurosci Lett. 2003; 343 (2): 93-96.
39. Kuo YM, Liao PC, Lin C, et al.Lack of association between Interleukin-1a polymorphism and Alzheimer disease or vascular dementia. Alz Dis Assoc Dis. 2003; 17 (2): 94-97.